For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250411:nRSK7525Ea&default-theme=true
RNS Number : 7525E Centrica PLC 11 April 2025
Centrica plc (the 'Company')
11 April 2025
Notification of Transactions of Directors
The Company was notified by Equiniti Limited, the administrators of the
Company's Share Incentive Plan (the 'Plan'), that Centrica plc ordinary shares
of 6 (14)/(81) pence ('Shares') have been acquired under the Plan.
The following notifications, made pursuant to Article 19 of the Market Abuse
Regulation, provide further details.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Christopher O'Shea
2 Reason for the notification
a) Position/status Executive Director
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Centrica plc
b) LEI E26EDV109X6EEPBKVH76
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial Ordinary shares of 6 (14)/(81) pence
instrument, type of instrument
Identification code GB00B033F229
b) Nature of the transaction Acquisition of Partnership Shares and Matching Shares on behalf of a PDMR by
Equiniti Share Plan Trustees Limited under the Company's Share Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.4309 105 (Partnership shares)
£1.3955 22 (Matching shares)
d) Aggregated information
Aggregated volume 127 Shares
- Price £1.425 per Share
- Total £180.95
e) Date of the transaction 10 April 2025
f) Place of the transaction London Stock Exchange (Partnership shares)
Outside a trading venue (Matching shares)
d)
Aggregated information
Aggregated volume
- Price
- Total
127 Shares
£1.425 per Share
£180.95
e)
Date of the transaction
10 April 2025
f)
Place of the transaction
London Stock Exchange (Partnership shares)
Outside a trading venue (Matching shares)
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Russell O'Brien
2 Reason for the notification
a) Position/status Executive Director
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Centrica plc
b) LEI E26EDV109X6EEPBKVH76
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial Ordinary shares of 6 (14)/(81) pence
instrument, type of instrument
Identification code GB00B033F229
b) Nature of the transaction Acquisition of Partnership Shares and Matching Shares on behalf of a PDMR by
Equiniti Share Plan Trustees Limited under the Company's Share Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.4309 104 (Partnership shares)
£1.3955 22 (Matching shares)
d) Aggregated information
Aggregated volume 126 Shares
- Price £1.425 per Share
- Total £179.51
e) Date of the transaction 10 April 2025
f) Place of the transaction London Stock Exchange (Partnership shares)
Outside a trading venue (Matching shares)
d)
Aggregated information
Aggregated volume
- Price
- Total
126 Shares
£1.425 per Share
£179.51
e)
Date of the transaction
10 April 2025
f)
Place of the transaction
London Stock Exchange (Partnership shares)
Outside a trading venue (Matching shares)
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGPUGUCUPAGWG